This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Irritability". See definition (new window)
An introduction to the psychopharmacology of children and adolescents with autism spectrum disorder.
Journal of Child and Adolescent Psychiatric Nursing
May, 29(2), pp. 62-71.
Review of the pharmacotherapy of irritability of autism.
Journal of the Canadian Academy of Child and Adolescent Psychiatry
21(2), pp. 130-146.
ElChaar G. M. et al. (2004)
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Mental Retardation and Developmental Disabilities Research Reviews
10(3), pp. 193-200.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-90.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Erickson C. A. , Mullett J. , McDougle C. J. (2010)
Brief report: acamprosate in fragile X syndrome.
Journal of Autism and Developmental Disorders
40(11), pp. 1412-1416.
Erickson C. A. et al. (2014)
Journal of Autism and Developmental Disorders
April, 44(4), pp. 981-987.
Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)
Open-label memantine in fragile X syndrome.
Journal of Autism and Developmental Disorders
39(12), pp. 1629-1635.
Erickson C. A. et al. (2014)
STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.
Journal of Autism and Developmental Disorders
44(4), pp. 958-964.
Farmer C. A. , Aman M. G. (2011)
Aripiprazole for the treatment of irritability associated with autism.
Expert Opinion on Pharmacotherapy
12(4), pp. 635-640
Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial
Journal of Autism and Developmental Disorders
28(4), pp. 303-307
Feingold Association of the United States (2008)
Symptoms that may be helped by the Feingold Program.
Riverhead, NY: Feingold Association of the United States
Frye R. E. et al. (2013)
Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.
Transcultural Psychiatry
3 e237.
Fung L. K. et al. (2014)
Journal of Autism and Developmental Disorders
November, 44(11), pp. 2971-2977.